News

February 2013

FDA: Consumer Warning for Male Sexual Enhancement Supplement

The U.S. Food and Drug Administration (FDA) recently issued a consumer warning for Super Power, a supplement for male sexual enhancement.

Manufactured by Freedom Trading, laboratory tests showed that Super Power, which was falsely marketed as a supplement, contained sildenafil, making it an unapproved drug. Sildenafil is a main ingredient in erectile dysfunction drugs.

An interaction between sildenafil and prescription drugs containing nitrates (such as nitroglycerin) may lower blood pressure to an unsafe level. Individuals taking nitrates often have diabetes, high blood pressure or cholesterol, or heart disease.

Freedom Trading has recalled one lot of Super Power.

Any consumer in possession of lot number L08108 of Super Power should discard the product immediately. Individuals taking Super Power should report any negative side effects to their healthcare provider and the FDA's MedWatch Safety Information and Adverse Event Reporting Program.

For more information about integrative therapies for erectile dysfunction, please visit Natural Standard's Comparative Effectivenessdatabase.

References

  1. Natural Standard: The Authority on Integrative Medicine. 
  2. US Food and Drug Administration. www.fda.gov

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.